National Estimates of the Adult Diabetes Care Continuum in India, 2019-2021
JAMA Internal Medicine · 01.09.2023 · 183 (9) · 963
DOI: 10.1001/jamainternmed.2023.3070 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.09.2023. Verfasst von Jithin Sam Varghese und 10 weiteren Autor:innen. Beteiligte Einrichtung: Emory Global Diabetes Research Center of Woodruff Health Sciences Center and Emory University, Atlanta, Georgia. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Importance Diabetes is widespread and treatable, but little is known about the diabetes care continuum (diagnosis, treatment, and control) in India and how it varies at the national, state, and district levels.
Objective
To estimate the adult population levels of diabetes diagnosis, treatment, and control in India at national, state, and district levels and by sociodemographic characteristics. Design, Setting, and Participants In this cross-sectional, nationally representative survey study from 2019 to 2021, adults in India from 28 states, 8 union territories, and 707 districts were surveyed for India’s Fifth National Family Health Survey (NFHS-5). The survey team collected data on blood glucose among all adults (18-98 years) who were living in the same household as eligible participants (pregnant or nonpregnant female individuals aged 15-49 years and male individuals aged 15-54 years). The overall sample consisted of 1 895 287 adults. The analytic sample was restricted to those who either self-reported having diabetes or who had a valid measurement of blood glucose. Exposures The exposures in this survey study were district and state residence; urban vs rural residence; age (18-39 years, 40-64 years, or ≥65 years); sex; and household wealth quintile. Main Outcomes and Measures Diabetes was defined by self-report or high capillary blood glucose (fasting: ≥126 mg/dL [to convert to mmol/L, multiply by 0.0555]; nonfasting: ≥220 mg/dL). Among respondents who had previously been diagnosed with diabetes, the main outcome was the proportion treated based on self-reported medication use and the proportion controlled (fasting: blood glucose <126 mg/dL; nonfasting: ≤180 mg/dL). The findings were benchmarked against the World Health Organization (WHO) Global Diabetes Compact targets (80% diagnosis; 80% control among those diagnosed). The variance in indicators between and within states was partitioned using variance partition coefficients (VPCs).
Results
Among 1 651 176 adult respondents (mean [SD] age, 41.6 [16.4] years; 867 896 [52.6%] female) with blood glucose measures, the proportion of individuals with diabetes was 6.5% (95% CI, 6.4%-6.6%). Among adults with diabetes, 74.2% (95% CI, 73.3%-75.0%) were diagnosed. Among those diagnosed, 59.4% (95% CI, 58.1%-60.6%) reported taking medication, and 65.5% (95% CI, 64.5%-66.4%) achieved control. Diagnosis and treatment were higher in urban areas, older age groups, and wealthier households. Among those diagnosed in the 707 districts surveyed, 246 (34.8%) districts met the WHO diagnosis target, while 76 (10.7%) districts met the WHO control target. Most of the variability in diabetes diagnosis (VPC, 89.1%), treatment (VPC, 85.9%), and control (VPC, 95.6%) were within states, not between states. Conclusions and Relevance In this survey study, the diabetes care continuum in India is represented by considerable district-level variation, age-related disparities, and rural-urban differences. Surveillance at the district level can guide state health administrators to prioritize interventions and monitor achievement of global targets.
Autor:innen und Institutionen
- Emory Global Diabetes Research Center of Woodruff Health Sciences Center and Emory University, Atlanta, Georgia.
- Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.
- Madras Diabetes Research Foundation and Dr Mohan's Diabetes Specialities Centre, Chennai, India.
- Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, California.
- Chan Zuckerberg Biohub-San Francisco, San Francisco, California.
- Professorship of Behavioral Science for Disease Prevention and Health Care, Technical University of Munich, Munich, Germany.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Varghese, J. S., Anjana, R. M., Geldsetzer, P., Sudharsanan, N., Manne-Goehler, J., Thirumurthy, H., Bhattacharyya, S., Narayan, K. M. V., Mohan, V., Tandon, N., & Ali, M. K. (2023). National Estimates of the Adult Diabetes Care Continuum in India, 2019-2021. JAMA Internal Medicine, 183(9), 963. https://doi.org/10.1001/jamainternmed.2023.3070
Vancouver
Varghese JS, Anjana RM, Geldsetzer P, Sudharsanan N, Manne-Goehler J, Thirumurthy H, et al. National Estimates of the Adult Diabetes Care Continuum in India, 2019-2021. JAMA Internal Medicine. 2023;183(9):963. doi:10.1001/jamainternmed.2023.3070
BibTeX
@article{Varghese2023,
author = {Varghese, Jithin Sam and Anjana, Ranjit Mohan and Geldsetzer, Pascal and Sudharsanan, Nikkil and Manne-Goehler, Jennifer and Thirumurthy, Harsha and Bhattacharyya, Soura and Narayan, K M Venkat and Mohan, Viswanathan and Tandon, Nikhil and Ali, Mohammed K},
title = {National Estimates of the Adult Diabetes Care Continuum in India, 2019-2021},
journal = {JAMA Internal Medicine},
year = {2023},
volume = {183},
number = {9},
pages = {963},
doi = {10.1001/jamainternmed.2023.3070}
}
EUVIMED